相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
Kohei Shitara et al.
GASTRIC CANCER (2017)
CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer
Se-Il Go et al.
CANCER RESEARCH AND TREATMENT (2016)
CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
Wen Min Lau et al.
CANCER RESEARCH (2014)
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
K. Hirata et al.
BRITISH JOURNAL OF CANCER (2013)
xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Momoko Yoshikawa et al.
CANCER RESEARCH (2013)
Redox regulation in stem-like cancer cells by CD44 variant isoforms
O. Nagano et al.
ONCOGENE (2013)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
In vivo assessment of cancerous tumors using boron doped diamond microelectrode
Stephane Fierro et al.
SCIENTIFIC REPORTS (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway
R-S Chen et al.
ONCOGENE (2009)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
分享论文
